Guru Ownership Trend
Guru Analysis for PTC Therapeutics, Inc. (PTCT)
PTC Therapeutics, Inc. (PTCT), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 8 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $168.87 M.
Top institutional holders include Jefferies Group and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bearish. This is evidenced by a $106.61 M net outflow during the quarter.
Recent activity highlights Paul Tudor Jones who increased their stake by 469.0%. Conversely, Manning & Napier Group reduced exposure by 88.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for PTC Therapeutics, Inc. (PTCT)
Major holders include Jefferies Group ($92.28 M), Renaissance Technologies (RenTech) ($36.33 M), Cliff Asness ($23.31 M). According to the latest reported data, 8 tracked investment managers collectively hold approximately 2.45 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $106.61 M, with 5 managers increasing positions and 7 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 4 fully exited PTCT. The total reported sell value was $115.89 M.
Yes, 2 managers opened new positions in PTCT, and 3 increased their existing holdings. The total reported buy value was $9.28 M.
